PATENT CLAIM ANALYSIS

Application Number: 16004918
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "562000"]

Abstract:
This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.

Claim (Index 6):
The composition of  claim 2 , wherein:\n l) the ratio of the L-amino acid entity to the R-amino acid entity is at least 1:4, or at least 2:5, and not more than 3:4; m) the ratio of the L-amino acid entity to the L-glutamine or a salt thereof is at least 1:4, or least 1:3, and not more than 3:4; n) the ratio of the R-amino acid entity to the L-glutamine or a salt thereof is at least 1:4, or least 1:2, and not more than 6:7; or o) a combination of two or three of (1)-(n).

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.20588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15858444', '13701146', '14563362', '14394463', '15229942']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7088514274959496
- 35 USC 102 Novelty (BERT): 0.5877460658351852
- Combined Prediction Score: 0.6967408913298733
- Mean Citation Score: 327.007784
- Max Citation Score: 599.9713
- Similarity Product: 359.3676680325092

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test